p27Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells

Cell Death and Differentiation

Volumn 15, Issue 5, 2008, Pages 908-919

  Wang, Q ^a   Zhou, Y ^a   Wang, X ^a   Evers, B M ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; S PHASE KINASE ASSOCIATED PROTEIN 2;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ALKALINE PHOSPHATASE; ANIMALS; BUTYRATES; CELL LINE, TUMOR; CELL NUCLEUS; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION;

EID: 42149170586     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.2     Document Type: Article

References (40)

1. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 1974; 141: 537-561.
2. Traber PG. Differentiation of intestinal epithelial cells: Lessons from the study of intestine-specific gene expression. J Lab Clin Med 1994; 123: 467-477.
3. Carethers JM. Cell checkpoints and enterocyte differentiation: A recipe for sequential stages focus on "Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4". Am J Physiol 1998; 275: C1191-C1192.
4. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
5. Koff A. How to decrease p27Kip1 levels during tumor development. Cancer cell 2006; 9: 75-76.
6. Litvak DA, Evers BM, Hwang KO, Hellmich MR, Ko TC, Townsend Jr CM. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 1998; 124: 161-169; discussion 169-170.
7. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jln O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NIF-kappaB activation. Nature 2000; 406: 86-90.
8. Marcus EA, Kintner C, Harris W. The role of GSK3beta in regulating neuronal differentiation in Xenopus laevis. Mol Cell Neurosci 1998; 12: 269-280.
9. Wang Q, Wang X, Hernandez A, Kim S, Evers, BM. Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroeterology 2001; 120: 1381-1392.
10. Heerdt BG, Houston MA, Augenlicht LH, Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 1994; 54: 3288-3293.
11. Ding QM, Ko TC, Evers BM. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol 1998; 275: C1193-C1200.
12. Haton C, Lebrun F, Benderitter M, Griffiths NM. Maintenance of differentiation capacity of HT-29 cells after radiation exposure. Int J Rediat Biol 2005; 81: 211-220.
13. Smith E, Coetzee GA, Frenkel B. Glucocorticoids inhibit cell cycle progression in differentiating osteeoblasts via glycogen synthase kinase-3beta. J Biol Chem 2002; 277: 1819l-18197.
14. Phiel CJ, Klein PS. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001; 41: 789-813.
15. Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc prateolysis and subnuclear localization. J Biol Chem 2003; 278: 51606-51612.
16. Santoni-Rugiu E, Falck J, Mailand N, Bartek J, Lukas J. Involvement of Myc activity in a G(1>/S-promoting mechanism parallel to the pRb/E2F pathway. Mol Cell 2000; 20: 3497-3509.
17. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ et al. Selective small molecule inhibitors of glycogen synthase kinass-3 modulate glycogen metabolism and gene transcription. Chem Biol 2000; 7: 793-803.
18. Jin ZH, Kurosu T, Yamaguchi M, Arai A, Miura O. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 2005; 24 1973-1981.
19. Zavitz KH, Zipursky SL. Controlling cell proliferation in difterentiating tissues: Genetic analysis of negative regulators of G1→ S-phase progression. Curr Opin Cell Biol 1997; 9: 773-781.
20. Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X et al. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci USA 2002; 99: 7951-7955.
21. Forde JE, Dale TC. Glycogen synthase kinase 3: A key regulator of cellular fate. Cell Mol Life Sci 2007, 64: 1930-1944.
22. Evers BM, Ko TC, Li J, Thompson EA. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am J Physiol 1996; 271: G722-G727.
23. Krasilnikov MA. Phosphatidylinositol-3 kinase dependent pathways: The role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 2000; 65: 59-67.
24. Ptasznik A, Beattie GM, Mally MI, Cirulli V, Lopez A, Hayek A. Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation. J Cell Biol 1997; 137: 1127-1136.
25. Tureckova J, Vojtechova M, Kucerova D, Velek J, Tuhackova Z. Sodium butyrate-mediated differentiation of colorectal cancer cells: Regulation of PKCbetaII by PI 3-kinase. Int J Mol Med 2005; 15: 329-335.
26. Deschenes C, Vezina A, Beaulieu JF, Rivard N. Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology 2001; 120: 423-438.
27. Quaroni A, Tian JQ, Seth P, Ap Rhys C. p27(Kip1) is an inducer of intestinal epithelial cell differentiation. Am J Physiol Cell Physiol 2000; 279: C1045-C1057.
28. Wang Q, Zhou Y, Wang X, Chung DH, Evers BM. Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-terminal kinase activation and nuclear factor-kappaB inhibition. Cancer Res 2007; 67: 7773-7781.
29. Appleman LJ, van Puijenbroek AA, Shu KM, Nadler LM, Boussiotis VA. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J Immunol 2002; 168: 2729-2736.
30. Alao JP, Stavropoulou AV, Lam EW, Coombes RC. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells. Mol Cancer 2006; 5: 40.
31. Chen CS, Weng SC, Tseng PH, Lin HP. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. J Biol Chem 2005; 280: 38879-38887.
32. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12: 3499-3511.
33. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M et al. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. J Biol Chem 2004; 279: 16495-16502.
34. Jonason JH, Gavrilova N, Wu M, Zhang H, Sun H. Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1. Cell cycle 2007; 6: 951-961.
35. Chen JS, Faller DV. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol 2005; 202: 87-99.
36. Timmerbeul I, Garrett-Engele CM, Kossatz U, Chen X, Firpo E, Grunwald V et al. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Proc Natl Acad Sci U S A 2006; 103: 14009-14014.
37. Dohda T, Maljukova A, Liu L, Heyman M, Grander D, Brodin D et al. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp Cell Res 2007; 313: 3141-3152.
38. Espinosa L, Ingles-Esteve J, Aguilera C, Bigas A. Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 2003; 278: 32227-32235.
39. Auld CA, Caccia CD, Morrison RF. Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways. J Cell Biochem 2007; 100: 204-216.
40. Surjit M, Lal SK. Glycogen synthase kinase-3 phosphorylates and regulates the stability of p27kip1 protein. Cell cycle 2007; 6 580-588.